PHGUF
PHARMING GROUP NV ORD by Pharming Group NV (PHGUF)
$
89About PHARMING GROUP NV ORD by Pharming Group NV (PHGUF)
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.99
52 Week Low
$0.74
Market cap
607.7M
Dividend yield
0.00%
Volume
--
Avg. volume
5
P/E ratio
-54.46
PHARMING GROUP NV ORD by Pharming Group NV News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.99
52 Week Low
$0.74
Market cap
607.7M
Dividend yield
0.00%
Volume
--
Avg. volume
5
P/E ratio
-54.46